Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies.
作者信息
Zimmer Jacques, Castriconi Roberta, Scaglione Silvia
机构信息
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Department of Experimental Medicine, University of Genova, Genova, Italy.
出版信息
Front Immunol. 2021 Nov 18;12:798493. doi: 10.3389/fimmu.2021.798493. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies.社论：用于测试免疫介导疗法的最新3D肿瘤模型
Front Immunol. 2021 Nov 18;12:798493. doi: 10.3389/fimmu.2021.798493. eCollection 2021.
2
Editorial: Anti-tumor activity of cytotoxic immune cells: basic research and clinical perspectives.
Front Immunol. 2024 May 15;15:1428565. doi: 10.3389/fimmu.2024.1428565. eCollection 2024.
3
A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization.可重现生物打印的 3D 肿瘤模型可作为 CAR T 细胞治疗优化的预选工具。
Front Immunol. 2021 Jun 29;12:689697. doi: 10.3389/fimmu.2021.689697. eCollection 2021.
4
Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.基于过继性细胞疗法和免疫检查点阻断疗法的实体瘤个性化联合免疫疗法的前景。
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):68-77. doi: 10.2177/jsci.40.68.
5
3D modeling in cancer studies.癌症研究中的三维建模。
Hum Cell. 2022 Jan;35(1):23-36. doi: 10.1007/s13577-021-00642-9. Epub 2021 Nov 10.
6
Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma - a Review.三维肝细胞癌细胞培养模型——综述。
J Gastrointest Cancer. 2021 Dec;52(4):1294-1308. doi: 10.1007/s12029-021-00772-1. Epub 2021 Dec 20.
7
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.采用 IL-2 细胞因子靶向肿瘤的抗癌疗法：固有、适应性和免疫抑制细胞在抗肿瘤疗效中的贡献。
Front Immunol. 2018 Dec 18;9:2905. doi: 10.3389/fimmu.2018.02905. eCollection 2018.
8
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy.针对肿瘤微环境和 T 细胞代谢的有效癌症免疫治疗。
Eur J Immunol. 2019 Aug;49(8):1147-1152. doi: 10.1002/eji.201848058. Epub 2019 Jul 9.
9
Advances in microfluidic 3D cell culture for preclinical drug development.用于临床前药物开发的微流控3D细胞培养技术进展。
Prog Mol Biol Transl Sci. 2022;187(1):163-204. doi: 10.1016/bs.pmbts.2021.07.022. Epub 2021 Sep 21.
10
Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer.社论：旨在增强基于自然杀伤细胞的癌症免疫疗法的分子策略
Front Immunol. 2020 Jun 16;11:1132. doi: 10.3389/fimmu.2020.01132. eCollection 2020.
引用本文的文献
1
Advances and Challenges in 3D Bioprinted Cancer Models: Opportunities for Personalized Medicine and Tissue Engineering.3D生物打印癌症模型的进展与挑战：个性化医学和组织工程的机遇
Polymers (Basel). 2025 Mar 31;17(7):948. doi: 10.3390/polym17070948.
2
A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma.一种基于3D生物打印的胰腺导管腺癌模型
Diseases. 2024 Sep 10;12(9):206. doi: 10.3390/diseases12090206.
3
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations.3D模型作为评估治疗性抗体抗肿瘤疗效的工具：优势与局限
Antibodies (Basel). 2022 Jul 8;11(3):46. doi: 10.3390/antib11030046.
本文引用的文献
1
Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer.器官芯片模型：胰腺癌精准医学的机遇
Cancers (Basel). 2021 Sep 6;13(17):4487. doi: 10.3390/cancers13174487.
2
Tumor organoid-originated biomarkers predict immune response to PD-1 blockade.肿瘤类器官衍生的生物标志物可预测 PD-1 阻断的免疫反应。
Cancer Cell. 2021 Sep 13;39(9):1187-1189. doi: 10.1016/j.ccell.2021.08.003. Epub 2021 Sep 2.
3
Tumor organoids: Opportunities and challenges to guide precision medicine.肿瘤类器官：精准医学的机遇与挑战
Cancer Cell. 2021 Sep 13;39(9):1190-1201. doi: 10.1016/j.ccell.2021.07.020. Epub 2021 Aug 19.
4
Tumour microenvironment 3D-modelling: simplicity to complexity and back again.肿瘤微环境的 3D 建模：从简单到复杂，再回到简单。
Trends Cancer. 2021 Nov;7(11):1033-1046. doi: 10.1016/j.trecan.2021.06.009. Epub 2021 Jul 24.
5
3D tumor spheroid microarray for high-throughput, high-content natural killer cell-mediated cytotoxicity.用于高通量、高内涵自然杀伤细胞介导的细胞毒性的 3D 肿瘤球体微阵列
Commun Biol. 2021 Jul 21;4(1):893. doi: 10.1038/s42003-021-02417-2.
6
Management of glioblastoma: State of the art and future directions.脑胶质瘤的治疗：现状与未来方向。
CA Cancer J Clin. 2020 Jul;70(4):299-312. doi: 10.3322/caac.21613. Epub 2020 Jun 1.
7
Neuroblastoma: An Updated Review on Biology and Treatment.神经母细胞瘤：生物学和治疗的最新综述。
Curr Drug Metab. 2019;20(13):1014-1022. doi: 10.2174/1389200221666191226102231.
8
Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer.肠道微生物群影响结直肠癌小鼠模型的实验结果。
Genes (Basel). 2019 Nov 7;10(11):900. doi: 10.3390/genes10110900.
9
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.慢性淋巴细胞白血病：2020 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Nov;94(11):1266-1287. doi: 10.1002/ajh.25595. Epub 2019 Oct 4.
10
Microfluidic 3D cell culture: potential application for tissue-based bioassays.微流控3D细胞培养：在基于组织的生物测定中的潜在应用。
Bioanalysis. 2012 Jun;4(12):1509-25. doi: 10.4155/bio.12.133.
Zotero 插件